Pages that link to "Q72228488"
Jump to navigation
Jump to search
The following pages link to Genetic alterations in bladder cancer (Q72228488):
Displaying 50 items.
- Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1 (Q24291362) (← links)
- Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene (Q24336560) (← links)
- Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome (Q28201662) (← links)
- Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis (Q30439612) (← links)
- Molecular genetic alterations in the laser‐capture–microdissected stroma adjacent to bladder carcinoma (Q33194314) (← links)
- Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand? (Q33915293) (← links)
- Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis (Q34080289) (← links)
- Applications of molecular diagnostics: solid tumor genetics can determine clinical treatment protocols (Q34194269) (← links)
- A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells (Q34587506) (← links)
- Profiling bladder cancer using targeted antibody arrays (Q35070783) (← links)
- Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis (Q35589281) (← links)
- Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas (Q35612218) (← links)
- Mouse models of human bladder cancer as a tool for drug discovery (Q35738385) (← links)
- Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome (Q35748945) (← links)
- Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization (Q35754504) (← links)
- Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder (Q35782360) (← links)
- Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma (Q35786216) (← links)
- Gene discovery in bladder cancer progression using cDNA microarrays (Q35791851) (← links)
- Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression (Q35795085) (← links)
- Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization (Q35798145) (← links)
- Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia (Q35798342) (← links)
- Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder (Q36079675) (← links)
- Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression (Q36095652) (← links)
- Urothelial tumorigenesis: a tale of divergent pathways (Q36234720) (← links)
- TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma (Q36309384) (← links)
- Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers (Q36363221) (← links)
- Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging (Q36675078) (← links)
- Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo (Q36820882) (← links)
- FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma (Q36882005) (← links)
- p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice (Q37061038) (← links)
- Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA (Q37113604) (← links)
- Hedgehog signaling regulates bladder cancer growth and tumorigenicity (Q37259384) (← links)
- Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis (Q37317523) (← links)
- Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome (Q37424793) (← links)
- Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. (Q37480033) (← links)
- Molecular pathways of urothelial development and bladder tumorigenesis (Q37770779) (← links)
- Fibroblast growth factor receptor-3 in urothelial tumorigenesis (Q37979516) (← links)
- Biomolecular predictors of urothelial cancer behavior and treatment outcomes (Q37987066) (← links)
- GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: a review of 25 cases (Q38191883) (← links)
- The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells (Q38833714) (← links)
- Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization (Q38871684) (← links)
- Recent advances in the molecular genetics of urogenital tumors (Q40456228) (← links)
- Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. (Q40526270) (← links)
- Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens (Q40838626) (← links)
- Biological determinants of bladder cancer gene expression subtypes (Q40861069) (← links)
- Genetic studies and molecular markers of bladder cancer (Q40883455) (← links)
- Genetic alterations in breast cancer. (Q40972502) (← links)
- Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target (Q41140293) (← links)
- Genetics of bladder cancer (Q41168576) (← links)
- Interphase cytogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization (Q41236837) (← links)